Status:

COMPLETED

HDL-Atherosclerosis Treatment Study (HATS)

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Coronary Disease

Eligibility:

All Genders

35-68 years

Phase:

PHASE3

Brief Summary

To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high dens...

Detailed Description

BACKGROUND: More than one-third of patients with coronary disease have "low" high density lipoprotein cholesterol (HDLc) levels (less than 35 mg/dl; United States 20th percentile) and "normal" low de...

Eligibility Criteria

Men and women with low HDL cholesterol, with at least one 50% stenotic coronary lesion or three 30% stenotic coronary lesions. Women range in age from 35 to less than 68 and men from 35 to less than 63.

Key Trial Info

Start Date :

September 1 1994

Trial Type :

INTERVENTIONAL

End Date :

February 1 2001

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00000553

Start Date

September 1 1994

End Date

February 1 2001

Last Update

February 10 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

HDL-Atherosclerosis Treatment Study (HATS) | DecenTrialz